Search Result "COG"
The Role of the COG Database in Comparative and Functional Genomics
Journal: Current Bioinformatics
Volume: 1 Issue: 3 Year: 2006 Page: 291-300
Author(s): Michael Kaufmann
Optimizing ADAS-Cog Worksheets: A Survey of Clinical Trial Rater sâ Perceptions
Journal: Current Alzheimer Research
Volume: 14 Issue: 9 Year: 2017 Page: 1008-1016
Author(s): Stephen M. Meyer,Kristina A. Bertzos,Magdalena Perez,Donald J. Connor,Kimberly Schafer,Sarah Walter
Reward-Seeking Behavior and Addiction: Cause or Cog?
Journal: Current Drug Abuse Reviews
Volume: 5 Issue: 3 Year: 2012 Page: 178-189
Author(s): Oscar Arias-Carrion,Mohamed Salama
Errors in ADAS-Cog Administration and Scoring May Undermine Clinical Trials Results
Journal: Current Alzheimer Research
Volume: 8 Issue: 4 Year: 2011 Page: 373-376
Author(s): K. Schafer, S. De Santi, L. S. Schneider
A Long-term Study of NeuroAid (MLC601, MLC901) in Patients withAlzheimer's Disease; An Extension 8-year Follow-up Study
Journal: Current Aging Science
Volume: 16 Issue: 3 Year: 2023 Page: 234-239
Author(s): Fatemeh Sadat Tabatabaei
Effects of Molecular Hydrogen Assessed by an Animal Model and a Randomized Clinical Study on Mild Cognitive Impairment
Journal: Current Alzheimer Research
Volume: 15 Issue: 5 Year: 2018 Page: 482-492
Author(s): Kiyomi Nishimaki,Takashi Asada,Ikuroh Ohsawa,Etsuko Nakajima,Chiaki Ikejima,Takashi Yokota,Naomi Kamimura,Shigeo Ohta
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful inScreening for Mild Cognitive Impairment and Alzheimer's Disease? ASystematic Review
Journal: Current Alzheimer Research
Volume: 19 Issue: 3 Year: 2022 Page: 202-211
Author(s): Kuem Sun Han
Evaluation of Putative Toxin-antitoxins Systems in Clinical Brucella melitensis in Iran
Journal: Infectious Disorders - Drug Targets
Volume: 21 Issue: 1 Year: 2021 Page: 38-42
Author(s): Safoura Moradkasani,Ebrahim Kouhsari,Faramarz Masjedian Jazi,Behrooz Sadeghi Kalani,Iraj Pakzad
Atorvastatin Therapy Lowers Circulating Cholesterol but not Free Radical Activity in Advance of Identifiable Clinical Benefit in the Treatment of Mild-to-Moderate AD
Journal: Current Alzheimer Research
Volume: 2 Issue: 3 Year: 2005 Page: 343-353
Author(s): D. Larry Sparks, Marwan N. Sabbagh, Donald J. Connor, Jean Lopez, Lenore J. Launer, Suzana Petanceska, Patrick Browne, Dawn Wassar, Sherry Johnson-Traver, Jeff Lochhead
Long-Term Response to Galantamine in Relation to Short-Term Efficacy Data: Pooled Analysis in Patients with Mild to Moderate Alzheimers Disease
Journal: Current Alzheimer Research
Volume: 8 Issue: 2 Year: 2011 Page: 175-186
Author(s): S. Kavanagh, I. Howe, H. R. Brashear, D. Wang, B. Van Baelen, M. Todd, S. Schwalen